4-(4-Fluoro-benzenesulfonyl)-piperidine hydrochloride, 95.0%, 1g

2-Fluorobenzyl mercaptan, 97.0%, 100g

Cyclopropanecarboxamide, N-[6-[4-[[[[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-4-pyrimidinyl]-, 98%, 25mg

Butanedioic acid, 2-hydroxy-, (2S)-, compd. with (3S,4S)-1,1-dimethylethyl 3-hydroxy-4-(methylamino)-1-pyrrolidinecarboxylate (1:1), 98%, 100mg

4-Amino-1,2,5-oxadiazole-3-carboxylic acid, 95.0%, 1g

3-(3-(9H-Carbazol-9-yl)phenyl)benzofuro[2,3-b]pyridine, 97%, 250mg

3-Bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine, 95.0%, 250mg

Acetyl Hydrazine, 97.0%, 25g

Tijeras anatómicas 140 mm. con punta puntiaguda y roma

Ethyl 4-(3-ethoxy-3-oxopropyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate, 95.0%, 5g

1-tert-Butoxycarbonylpyrrolidine>98.0%(GC)25g

7-Hydroxy-5-methoxy-2,3-dihydro-1H-inden-1-one, 95.0%, 100mg

Monohidrato de 1,10-fenantrolina, mínimo 99 %, pa, ACS, 50 g, envase de vidrio